Theravance Biopharma Inc.
8.64
0.11 (1.29%)
At close: Jan 15, 2025, 3:59 PM
8.61
-0.35%
After-hours Jan 15, 2025, 04:00 PM EST

Theravance Biopharma Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Collaboration revenue Revenue 16.87M 14.50M 21.23M 19.30M 6.00K 5.00K 18.70M 17.20M 15.30M
Collaboration revenue Revenue Growth +16.31% -31.67% +9.97% +321566.67% +20.00% -99.97% +8.72% +12.42% n/a
YUPELRI Monotherapy Revenue 21.77M 19.33M n/a 6.00K 16.40M n/a 6.00K n/a n/a
YUPELRI Monotherapy Revenue Growth +12.61% n/a n/a -99.96% n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015
Europe Revenue 223.00K 222.00K 38.00K 1.54M 18.65M 11.12M 1.11M 15.21M 21.35M
Europe Revenue Growth +0.45% +484.21% -97.53% -91.76% +67.80% +902.43% -92.71% -28.77% n/a
United States Revenue 57.20M 51.12M 55.27M n/a n/a n/a n/a n/a n/a
United States Revenue Growth +11.89% -7.51% n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 16.88M 17.06M 15.64M 15.49M 16.14M 19.28M 19.18M 16.73M 16.28M 16.99M 23.64M 21.52M 21.30M 25.93M 30.55M 30.05M 27.50M 24.78M 26.32M 33.05M 25.62M 22.23M 25.19M 25.46M 21.89M 25.01M 24.70M 29.52M 20.94M 24.34M 20.79M 20.37M 20.29M 20.26M 23.60M 24.06M 22.84M 21.55M 21.75M
Selling, General, and Administrative Revenue Growth -1.06% +9.05% +0.96% -4.03% -16.27% +0.50% +14.63% +2.81% -4.17% -28.14% +9.86% +1.02% -17.86% -15.12% +1.65% +9.29% +10.98% -5.87% -20.34% +28.98% +15.27% -11.75% -1.06% +16.30% -12.46% +1.23% -16.33% +40.97% -13.95% +17.09% +2.06% +0.39% +0.12% -14.13% -1.94% +5.34% +6.03% -0.93% n/a
Research and Development Revenue 9.27M 9.95M 8.54M 8.31M 8.31M 9.43M 14.57M 15.35M 9.87M 15.57M 23.25M 31.23M 43.74M 51.09M 67.60M 65.17M 67.37M 62.40M 66.01M 67.03M 52.01M 46.40M 53.82M 52.27M 52.69M 48.62M 47.77M 51.05M 39.34M 42.93M 40.56M 42.01M 31.95M 32.07M 35.68M 32.40M 30.37M 30.38M 36.02M
Research and Development Revenue Growth -6.89% +16.61% +2.67% +0.04% -11.82% -35.32% -5.05% +55.54% -36.63% -33.04% -25.53% -28.61% -14.39% -24.42% +3.74% -3.27% +7.96% -5.47% -1.51% +28.88% +12.08% -13.79% +2.96% -0.80% +8.37% +1.79% -6.44% +29.76% -8.35% +5.82% -3.45% +31.49% -0.37% -10.12% +10.11% +6.70% -0.03% -15.66% n/a

Create Price Alert on TBPH

Your price alert will notify you when the stock price is above 8.64.

Add to Watchlist